Hyman Charles D Moderna, Inc. Transaction History

Hyman Charles D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $174,610 - $309,809	1,475 New	1,475 $264,000
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $172,766 - $260,470	1,475 New	1,475 $211,000
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $120,813 - $197,152	-535 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $118,716 - $259,191	535 New	535 $206,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

Stay updated on Hyman Charles D with notifications on news.